Healthy Skepticism logo = snake coiled around pen over globe Healthy Skepticism

Countering misleading drug promotion

Home | About us | Site info | Contact us | Links | Other
What's new | AdWatch | HS Int News | Library | Fora
Home - www.healthyskepticism.org > library > topics: best : Updated 22 August, 2005


Free Updates
Can we help you?


Join in

Subscribe to Healthy Skepticism Updates


If you like our work please tell others.
If not, please tell us.

Best of the Healthy Skepticism Library


This page lists the best 80 references in the Main Healthy Skepticism Library chosen by Peter Mansfield.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.


HSL2484
Smith R.
Curbing the Influence of the Drug Industry: A British View.
PLoS Med 2005 Aug 2;2(9):e241
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020241

HSL2429
Adair RF, Holmgren LR.
Do drug samples influence resident prescribing behavior? A randomized trial.
Am J Med 2005 Aug;118(8):881-4
http://www.amjmed.com/article/PIIS000293430500197X/fulltext

HSL1985
Zipkin DA, Steinman MA.
Interactions Between Pharmaceutical Representatives and Doctors in Training: A thematic review.
J Gen Intern Med 2005 Jun 13;20(8):777-86
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.0134.x

HSL2388
Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, Henderson KM, Maguire J, Stokes BJ, Macdonald GJ, Day RO.
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.
Med J Aust 2005 Jun 6;182(11):557-60
http://www.mja.com.au/public/issues/182_11_060605/hen10805_fm.html

HSL2430
Freudenberg N.
Public health advocacy to change corporate practices: implications for health education practice and research.
Health Educ Behav 2005 Jun;32(3):298-319
http://heb.sagepub.com/cgi/reprint/32/3/298

HSL1930
Brodkey AC.
The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
Acad Psychiatry 2005 Sum;29(2):222-9
http://ap.psychiatryonline.org/cgi/content/full/29/2/222

HSL1979
Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P.
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
JAMA 2005 Apr 27;293(16):1995-2002
http://jama.ama-assn.org/cgi/content/full/293/16/1995

HSL2387
Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K.
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Intern Med J 2005 Apr;35(4):206-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1444-0903.2004.00799.x

HSL2383
Mansfield PR, Mintzes B, Richards D, Toop L.
Direct to consumer advertising.
BMJ 2005 Jan 1;330(7481):5-6
http://bmj.bmjjournals.com/cgi/content/full/330/7481/5

HSL2
Mansfield P.
Accepting what we can learn from advertising's mirror of desire.
BMJ 2004 Dec 18;329(7480):1487-8
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15604193

HSL2389
Scott T, Stanford N, Thompson DR.
Killing me softly: myth in pharmaceutical advertising.
BMJ 2004 Dec 18;329(7480):1484-7
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15604192

HSL1897
Douglas KM, Sutton RM.
Right about others, wrong about ourselves? Actual and perceived self-other differences in resistance to persuasion
Br J Soc Psychol 2004 Dec;43(Pt 4):585-603
http://www.ingentaconnect.com/content/bpsoc/bjsp/2004/00000043/00000004/art00007?token=005c10cc4e7247444f6d6222346b62687633502b333e3541333c4a2f246c6a38574b675423783c77eefc266e7e60

HSL487
Mansfield PR, Henry D.
Misleading drug promotion--no sign of improvements.
Pharmacoepidemiol Drug Saf 2004 Nov;13(11):797-9
http://www3.interscience.wiley.com/cgi-bin/abstract/107632790/ABSTRACT

HSL500
Sweet M.
Doctors and drug companies are locked in 'vicious circle'.
BMJ 2004 Oct 30;329(7473):998
http://bmj.bmjjournals.com/cgi/content/full/329/7473/998

HSL1351
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May;79(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432

HSL1663
Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
Lancet 2004 Apr 24;363(9418):1341-5
http://linkinghub.elsevier.com/retrieve/pii/S0140673604160431

HSL257
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19;180(8):411-4
http://www.mja.com.au/public/issues/180_08_190404/rog10715_fm.html

HSL2083
Breen KJ.
The medical profession and the pharmaceutical industry: when will we open our eyes?
Med J Aust 2004 Apr 19;180(8):409-10
http://www.mja.com.au/public/issues/180_08_190404/bre10055_fm.html

HSL258
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL.
Efficacy and safety of antidepressants for children and adolescents.
BMJ 2004 Apr 10;328(7444):879-83
http://bmj.com/cgi/content/full/328/7444/879

HSL671
Schafer A.
Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
J Med Ethics 2004 Feb;30(1):8-24
http://jme.bmjjournals.com/cgi/content/full/30/1/8

HSL1340
Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-Jun;Suppl Web Exclusives:W4-234-45
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.234v1

HSL489
Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb;73(1):10-6
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=PPS2004073001010

HSL1413
Mansfield PR.
Healthy Skepticism's new AdWatch: understanding drug promotion.
Med J Aust 2003 Dec 1-15;179(11-12):644-5
http://www.mja.com.au/public/issues/179_11_011203/man10667_fm.html

HSL1037
Katz D, Mansfield P, Goodman R, Tiefer L, Merz J.
Psychological aspects of gifts from drug companies.
JAMA 2003 Nov 12;290(18):2404-5
http://jama.ama-assn.org/cgi/content/full/290/18/2404-b

HSL2426
Dana J, Loewenstein G.
A social science perspective on gifts to physicians from industry.
JAMA 2003 Jul 9;290(2):252-5
http://jama.ama-assn.org/cgi/content/full/290/2/252

HSL566
Mansfield PR.
Bribes for doctors: a gift for bioethicists?
Am J Bioeth 2003 Summer;3(3):47-8
Nil

HSL1459
Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ 2003 Apr 29;168(9):1133-7
http://www.cmaj.ca/cgi/content/full/168/9/1133

HSL1453
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The quantity and quality of scientific graphs in pharmaceutical advertisements.
J Gen Intern Med 2003 Apr;18(4):294-7
http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0884-8734&date=2003&volume=18&issue=4&spage=294

HSL2441
Prosser H, Almond S, Walley T.
Influences on GPs' decision to prescribe new drugs-the importance of who says what.
Fam Pract 2003 Feb;20(1):61-8
http://fampra.oxfordjournals.org/cgi/content/full/20/1/61

HSL1383
Villanueva P, Peiro S, Librero J, Pereiro I.
Accuracy of pharmaceutical advertisements in medical journals.
Lancet 2003 Jan 4;361(9351):27-32
http://linkinghub.elsevier.com/retrieve/pii/S0140673603121186

HSL302
Katz D, Caplan AL, Merz JF.
All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Am J Bioeth 2003;3(3):39-46
http://www.ingentaconnect.com/content/routledg/ajob/2003/00000003/00000003/art00027

HSL1420
Braithwaite J.
Restorative Justice and Responsive Regulation
Oxford: Oxford University Press; 2002
http://www.oup.co.uk/isbn/0-19-515839-3

HSL2217
Brotons C, Moral I, Ribera A, Cascant P, Iglesias M, Permanyer-Miralda G, Ferreira Gonzalez I, Soler-Soler J.
[Methods of reporting research-results and their influence on decision-making by cardiologists prescribing drugs for primary and secondary prevention.]
Rev Esp Cardiol 2002 Oct;55(10):1042-51
http://www.revespcardiol.org/cgi-bin/wdbcgi.exe/cardio/cardioeng.acceso_full.alta

HSL2610
Loke TW, Koh FC, Ward JE.
Pharmaceutical advertisement claims in Australian medical publications.
Med J Aust 2002 Sep 16;177(6):291-3
http://www.mja.com.au/public/issues/177_06_160902/lok10004_fm.html

HSL1893
Sagarin BJ, Cialdini RB, Rice WE, Serna SB.
Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion.
J Pers Soc Psychol 2002 Sep;83(3):526-41
http://content.apa.org/journals/psp/83/3/526

HSL2437
Hall KH.
Reviewing intuitive decision-making and uncertainty: the implications for medical education.
Med Educ 2002 Mar;36(3):216-24
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2923.2002.01140.x

HSL113
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
BMJ 2002;324:278-279
http://bmj.bmjjournals.com/cgi/content/full/324/7332/278

HSL117
Choudhry NK, Stelfox HT, Detsky AS
Relationships between authors of clinical practice guidelines and the pharmaceutical industry
JAMA 2002;287:612-617
http://jama.ama-assn.org/cgi/content/full/287/5/612

HSL119
Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001 Dec;76(12):1271-1277
http://www.academicmedicine.org/cgi/content/full/76/12/1271

HSL2382
Sackett DL.
Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).
CMAJ 2001 Oct 30;165(9):1226-37
http://www.cmaj.ca/cgi/content/full/165/9/1226

HSL2510
McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS.
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
JAMA 2001 Oct 24-31;286(16):1994-9
http://jama.ama-assn.org/cgi/content/full/286/16/1994

HSL129
Jones MI, Greenfield SM, Bradley CP.
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2001;323:378-384
http://bmj.bmjjournals.com/cgi/content/full/323/7309/378

HSL118
Woloshin S, Schwartz LM, Tremmel J, Welch HG
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
Lancet 2001;358:1141-1146
http://linkinghub.elsevier.com/retrieve/pii/S0140673601062547

HSL122
Sigworth SK, Nettleman MD, Cohen GM.
Pharmaceutical branding of resident physicians
JAMA 2001;JAMA:1024-1025
http://jama.ama-assn.org/cgi/content/full/286/9/1024-a

HSL2405
Ainslie G.
Breakdown of Will
Cambridge: Cambridge University Press; 2001
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521596947

HSL2459
Norman GR.
The epistemology of clinical reasoning: perspectives from philosophy, psychology, and neuroscience.
Acad Med 2000 Oct;75(10)
http://www.academicmedicine.org/cgi/content/full/75/10/S127?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Norman+G&titleabstract=epistemology&searchid=1124492605605_451&stored_search=&FIRSTINDEX=0&journalcode=acadmed

HSL339
Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB.
Coverage by the news media of the benefits and risks of medications.
N Engl J Med 2000 Jun 1;342(22):1645-50
http://content.nejm.org/cgi/content/full/342/22/1645

HSL2406
Sutherland M, Sylvester AK.
Advertising and the Mind of the Consumer 2nd Ed: What works, what doesn't, and why.
Sydney: Allen & Unwin; 2000
http://www.allen-unwin.com.au/Shopping/SearchResults.aspx?search=Advertising+and+the+Mind+of+the+Consumer+

HSL1766
Cialdini RB.
Influence: Science and Practice 4th Edn
New York: Allyn & Bacon; 2000
http://www.ablongman.com/catalog/academic/product/0,1144,0321011473,00.html

HSL2390
Braithwaite J, Drahos P.
Global business regulation.
Cambridge: Cambridge University Press; 2000
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521784999

HSL2436
Elstein AS.
Heuristics and biases: selected errors in clinical reasoning.
Acad Med 1999 Jul;74(7):791-4
Nil

HSL540
Kamat VR, Nichter M.
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India.
Soc Sci Med 1998 Sep;47(6):779-94
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-3T3SS6V-1H&_coverDate=09%2F16%2F1998&_alid=305663279&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=77260eaace668b4e4f2bdc8361b37ee6

HSL517
Roughead EE, Harvey KJ, Gilbert AL.
Commercial detailing techniques used by pharmaceutical representatives to influence prescribing.
Aust N Z J Med 1998 Jun;28(3):306-10
Nil

HSL548
Stelfox HT, Chua G, O'Rourke K, Detsky AS.
Conflict of interest in the debate over calcium-channel antagonists.
N Engl J Med 1998 Jan 8;338(2):101-6
http://content.nejm.org/cgi/content/abstract/338/2/101

HSL519
Roughead EE, Gilbert AL, Harvey KJ.
Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?
Int J Health Serv 1998;28(2):269-79
Nil

HSL2218
Lexchin J.
What information do physicians receive from pharmaceutical representatives?
Can Fam Physician 1997 May;43:941-5
Nil

HSL2385
Stryer D, Bero LA.
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
J Gen Intern Med 1996 Oct;11(10):575-83
Nil

HSL744
Wolfe S.
Drug advertisements that go straight to the hippocampus.
Lancet 1996 Sep 7;348(9028):632
Nil

HSL2391
Estes R.
Tyrany of the bottom line: Why corporations make good people do bad things.
San Francisco: Berrett-Koehler; 1996
http://www.bkconnection.com/ProdDetails.asp?ID=1881052753&PG=1&Type=BL&PCS=BKP

HSL2428
Barlow J, Møller C.
A complaint is a gift. Using customer feedback as a strategic tool.
San Francisco: Berrett-Koehler; 1996
http://www.bkconnection.com/ProdDetails.asp?ID=1881052818&PG=1&Type=RLMa&PCS=BKP

HSL811
Ziegler MG, Lew P, Singer BC.
The accuracy of drug information from pharmaceutical sales representatives.
JAMA 1995 Apr 26;273(16):1296-8
Nil

HSL2427
Ogilvy D.
Ogilvy on advertising.
London: Prion; 1995
http://www.randomhouse.com/vintage/catalog/display.pperl?isbn=9780394729039

HSL2453
Branthwaite A, Downing T.
Marketing to doctors - the human factor.
Scrip Magazine 1995:32-5
Nil

HSL498
Lexchin J.
Deception by design: Pharmaceutical promotion in the Third World
Penang: Consumers International; 1995
Nil

HSL1719
Bardelay D, Bécel B.
Visits from medical representatives: fine principles, poor practice
Prescrire International 1995;4(18):120-122
Nil

HSL7047
Shaughnessy AF, Slawson DC, Bennett JH.
Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion.
J Gen Intern Med 1994 Oct;9(10):563-8
Nil

HSL7046
Scott DK, Ferner RE.
'The strategy of desire' and rational prescribing.
Br J Clin Pharmacol 1994 Mar;37(3):217-9
Nil

HSL2395
Ayres I, Braithwaite J.
Responsive regulation: Transcending the deregulation debate.
Oxford: Oxford University Press; 1992
http://www.oup.co.uk/isbn/0-19-509376-3

HSL2407
Mansfield PR.
Classifying improvements to drug marketing and justifications for claims of efficacy.
Int J Risk Safety Med 1991;2:171-84
Nil

HSL2414
Hutcheon L, Hutcheon M.
Medical “mythologies”: a semiotic approach to pharmaceutical advertising.
Queen's Q 1987;94:904-16
Nil

HSL1560
Goleman D.
Vital lies, simple truths: The psychology of self-deception.
London: Bloomsbury; 1985
http://www.amazon.com/exec/obidos/tg/detail/-/0684831074/103-6888207-0054229?v=glance

HSL2425
Avorn J, Chen M, Hartley R.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
Am J Med 1982 Jul;73(1):4-8
Nil

HSL2435
Kahneman D, Slovic P, Tversky A.
Judgment under uncertainty: heuristics and biases.
New York: Cambridge University Press; 1982
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521284147

HSL2440
Hamblin CL.
Fallacies
London: Methuen; 1970
http://www.valepress.com/Fallacies.htm

HSL2399
Fischer DH.
Historian's Fallacies: Toward a logic of historical thought.
New York: Harper Torchbooks; 1970
http://www.amazon.com/exec/obidos/tg/detail/-/0061315451/002-4340062-2313626?v=glance

HSL2415
Talalay P, Editor.
Drugs in Our Society.
Baltimore: John Hopkins Press; 1964
http://www.amazon.com/exec/obidos/tg/detail/-/0801806194/qid=1124494429/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books

HSL2393
Hopkins CC.
My Life in Advertising.
Chicago: 1996 reprint by NTC Business Books; 1927
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=

HSL2394
Hopkins CC.
Scientific advertising.
Chicago: 1996 reprint by NTC Business Books; 1923
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=

HSL860
Locke J.
An essay concerning human understanding
1690
http://etext.library.adelaide.edu.au/l/locke/john/l81u/index.html

HSL859
Aristotle.
Rhetoric.
Date uncertain
http://www.public.iastate.edu/~honeyl/Rhetoric/index.html

1645 visits to this page since 1 January 2007